Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies Limited disclosed on 10-11-2026 that as at 09-11-2026 it holds economic exposure to Advanced Medical Solutions Group plc via 8,039,183 cash-settled derivatives representing 3.63% of the 5p ordinary share capital, with 0 ordinary shares owned and 0 short positions; the filing records an equity-swap trade increasing a long position by 926 units at GBp 282.50 and confirms 0 stock-settled derivatives, 0 subscription rights, no indemnity/arrangement and no Supplemental Form 8 attached.

Disclaimer*

UK 100